Limited prognostic value of tumor necrosis in patients with renal cell carcinoma (Q44075867)

29 November 2017

Limited prognostic value of tumor necrosis in patients with renal cell carcinoma (English)

1 reference

29 November 2017

3

1 reference

29 November 2017

Nathalie Rioux-Leclercq

series ordinal

4

object named as

Nathalie Rioux-Leclercq

1 reference

29 November 2017

2

Jean-Jacques Patard

1 reference

29 November 2017

Arnauld Villers

9

0 references

Pierre I Karakiewicz

series ordinal

12

object named as

Pierre I Karakiewicz

1 reference

29 November 2017

10

Shahrokh F Shariat

1 reference

29 November 2017

Alexandre de la Taille

series ordinal

7

object named as

Alexandre de la Taille

1 reference

29 November 2017

1

Hendrik Isbarn

1 reference

29 November 2017

6

Luca Cindolo

1 reference

29 November 2017

8

Laurent Zini

1 reference

29 November 2017

5

Maxime Crépel

1 reference

29 November 2017

11

Roberto Bertini

1 reference

29 November 2017

language of work or name

English

0 references

publication date

25 September 2009

1 reference

29 November 2017

1 reference

29 November 2017

75

1 reference

29 November 2017

6

1 reference

29 November 2017

1378-1384

1 reference

Renal cell carcinoma guideline

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.07.1221

Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.07.1221

Multi-institutional validation of a new renal cancer-specific survival nomogram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.07.1221

External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.07.1221

Judging New Markers by Their Ability to Improve Predictive Accuracy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.07.1221

Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.07.1221

Correlation between symptom graduation, tumor characteristics and survival in renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.07.1221

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.07.1221

Evaluating the yield of medical tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.07.1221

External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.07.1221

Prognostic Role of Histological Necrosis for Nonmetastatic Clear Cell Renal Cell Carcinoma: Correlation With Pathological Features and Molecular Markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.07.1221

Presence of tumor necrosis is not a significant predictor of survival in clear cell renal cell carcinoma: higher prognostic accuracy of extent based rather than presence/absence classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.07.1221

Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.07.1221

Platelet count and preoperative haemoglobin do not significantly increase the performance of established predictors of renal cell carcinoma-specific mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.07.1221

Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.07.1221

Prognostic value of thrombocytosis in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.07.1221

ECOG performance status 0 or 1 and symptom classification do not improve the ability to predict renal cell carcinoma-specific survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.07.1221

C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.07.1221

Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.07.1221

Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.07.1221

Improved prognostication of renal cell carcinoma using an integrated staging system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.07.1221

10.1016/J.UROLOGY.2009.07.1221

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference